PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -31.1% | 20,149 | +0.7% | 0.00% | – |
| Q2 2023 | $90 | – | 20,000 | +21639.1% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 92 | -98.2% | 0.00% | – |
| Q1 2022 | $34,000 | -69.9% | 4,992 | -45.1% | 0.00% | – |
| Q4 2021 | $113,000 | -60.4% | 9,092 | -0.2% | 0.00% | – |
| Q3 2021 | $285,000 | +9.6% | 9,109 | +0.4% | 0.00% | – |
| Q2 2021 | $260,000 | -33.3% | 9,075 | +0.8% | 0.00% | – |
| Q1 2021 | $390,000 | -24.3% | 9,000 | +25.0% | 0.00% | -100.0% |
| Q4 2020 | $515,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $52,407,000 | 0.95% |
| Baker Brothers Advisors | 10,123,824 | $52,846,000 | 0.30% |
| Corton Capital Inc. | 15,586 | $81,000 | 0.08% |
| HHLR ADVISORS, LTD. | 583,333 | $3,045,000 | 0.06% |
| Delphia (USA) Inc. | 16,940 | $88,000 | 0.06% |
| Rock Springs Capital Management LP | 368,959 | $1,926,000 | 0.06% |
| Virtus ETF Advisers LLC | 24,005 | $125,000 | 0.05% |
| CAXTON ASSOCIATES LP | 83,867 | $438,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 36,626 | $191,000 | 0.03% |
| PDT Partners, LLC | 43,731 | $228,000 | 0.02% |